Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2024 Oct 14;131(10):1716–1717. doi: 10.1038/s41416-024-02850-0

Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus

Masashi Hashimoto 1, Shinji Kuroda 1,2,✉, Nobuhiko Kanaya 1, Daisuke Kadowaki 1, Yusuke Yoshida 1, Masaki Sakamoto 1, Yuki Hamada 1, Ryoma Sugimoto 1, Chiaki Yagi 1, Tomoko Ohtani 1, Kento Kumon 1, Yoshihiko Kakiuchi 1,2, Kazuya Yasui 1, Satoru Kikuchi 1, Ryuichi Yoshida 1, Hiroshi Tazawa 1,3, Shunsuke Kagawa 1,4, Takahito Yagi 1, Yasuo Urata 5, Toshiyoshi Fujiwara 1
PMCID: PMC11555113  PMID: 39402325

Correction to: British Journal of Cancer 10.1038/s41416-024-02583-0, published online 5 February 2024

In Fig. 4b, Uninjected site, the labels for ‘GN+702’ and ‘GN+702 +anti-CD8α’ were incorrectly placed; the labels should be transposed, as shown in the corrected figure presented here.graphic file with name 41416_2024_2850_Figa_HTML.jpg

In Fig. 5c, After re-inoculation, the labels for ‘GN+702’ and ‘GN+702 +anti-CD8α’ were incorrectly placed; the labels should be transposed, as shown in the corrected figure presented here.graphic file with name 41416_2024_2850_Figb_HTML.jpg

The correction does not have any effect on the results or conclusions of the paper.

The original article has been corrected.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES